Aandeel QTXB QUANTRX BIOMEDICAL CORPORATION
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen QuantRx Biomedical Corporation

Aandelen

QTXB

US74765N1090

Beurs gesloten - OTC Markets
Andere beurzen
 19:37:42 26-02-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
0,004 USD -.--% Intraday-grafiek van QuantRx Biomedical Corporation -.--% -49,37%
2022 QuantRx Biomedical Corporation rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2022 CI
2022 Michael Abrams treedt af als lid van de Raad van Bestuur van QuantRx Biomedical Corporation CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
QUANTRX BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
QuantRx Biomedical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
QuantRx Biomedical : Management Change/Compensation - Form 8-K
Michael Abrams Resigns as a Member of the Board of Directors of QuantRx Biomedical Corporation
QUANTRX BIOMEDICAL CORP : Change in Directors or Principal Officers (form 8-K)
QUANTRX BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
QuantRx Biomedical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
QUANTRX BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
QuantRx Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022
QUANTRX BIOMEDICAL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
QuantRx Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2021
QuantRx Biomedical Corporation Auditor Raises 'Going Concern' Doubt
QUANTRX BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
QuantRx Biomedical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
QUANTRX BIOMEDICAL : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Quantrx Biomedical Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021
QUANTRX BIOMEDICAL : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Quantrx Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021
QUANTRX BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Quantrx Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2020
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers QTXB
  4. Nieuws QuantRx Biomedical Corporation
  5. Andere talen